Tune into this episode of Covington’s Life Sciences Audiocast, where Winsome Cheung, Lauren Pignataro Rakitin and Sibel Yilmaz discuss cell and gene therapy collaboration and licensing deals. The speakers discuss the commercial, IP and antitrust issues commonly faced by pharma and biotech companies as they seek to partner
Continue Reading EU Talking Life Sciences Audiocast: The Evolving Landscape of Cell and Gene Therapy Deals – An Introduction to Licensing and Collaboration TransactionsLauren Pignataro Rakitin
Lauren Pignataro Rakitin specializes in transactional matters in the life sciences industry, with a particular focus on complex strategic collaborations and licensing arrangements. Lauren advises a broad range of clients, from start-up and biotech companies to global pharmaceutical companies. By focusing exclusively in the life sciences industry, Lauren has established a deep understanding of the complex needs of pharmaceutical and biotechnology companies as they navigate the life cycle of their products, from discovery and development to commercialization and generic/biosimilar entry.
Lauren routinely advises on:
- strategic licensing and collaboration agreements for the discovery, development and/or commercialization of life sciences products;
- in-licensing of foundational IP and out-licensing of IP that is no longer core to the portfolio to unlock further value; and
- commercial agreements, including CRO, clinical trial, manufacturing, co-promotion and distribution agreements.